Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
14 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
RevaTis from Marche-en-Famenne, company number BE0541682642, closed financial year 2025 with a result of € -620,715 after tax. For that financial year RevaTis recorded a gross margin of € 136,602 and equity of € 2.6 million. Compared with financial year 2024, the result moved from € -262,021 to € -620,715. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ 2.6 million
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -620,715
▼ 137 % more loss than in 2024
Profit after tax over the fiscal year.
€ 371,672
▲ 46% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1.9 million.
People and assets in 2025
€ 416,306
▼ 15% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,384
▼ 46% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 549,828
▲ 1% vs 2024
Loans from banks and other lenders, long and short.
€ 585,442
▲ 50% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 50,544
▲ 18% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 688,155 | € 582,301 | € 606,821 | € 136,602 | ▼ 77% |
| Profit after taxes | € 48,252 | € -222,319 | € -262,021 | € -620,715 | ▼ € 358,695 |
| Equity | € 2,487,369 | € 2,737,550 | € 2,475,530 | € 2,551,321 | ▲ 3% |
| Total debts | € 1,034,495 | € 1,095,467 | € 1,162,875 | € 1,563,693 | ▲ 34% |
| Cash | € 454,089 | € 371,276 | € 255,417 | € 371,672 | ▲ 46% |
| Retained profit | € -792,931 | € -1,015,250 | € -1,277,270 | € -1,916,479 | ▼ € 639,209 |
| Bank debt | € 322,787 | € 349,392 | € 543,570 | € 549,828 | ▲ 1% |
| Balance sheet total | € 3,521,865 | € 3,833,017 | € 3,638,405 | € 4,115,014 | ▲ 13% |
| Employees (FTE) | - | 5.6 | 5.7 | - |
Key figures of RevaTis, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to RevaTis?
What happened at RevaTis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 620,715. Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Marche-en-Famenne. KBO
In short
From € 48,252 profit in 2022 to € 620,715 loss in 2025.
Paid € 2,401 in corporate taxes since 2022.
Best year ever: 2022, with € 48,252 profit.
On average € 106,500 of value added per employee in 2024.
Management
The stake of NOSHAQ SPIN-OFFS, ECG Labs, salamander U comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
RevaTisBehind RevaTis are NOSHAQ PARTNERS, Jean-Paul LACOMBLE, Jean-Luc MARTIN, Jacques KUYPERS, SALAMANDER U. and Philippe NEVEN. The shares are held by NOSHAQ SPIN-OFFS (18.4%), ECG Labs (10%) and salamander U (3.7%).
Directors
According to the 2025 annual accounts
Director · represented by Frédéric SCHYNTS
Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, Fonderies J. Marichal Ketin et Cie, DARDENNE, SOGECOM, VITAVERDE.BIO, HAEMERS Technologies, SPACEBEL, NOSHAQ VENTURE +169 more
Jean-Paul LACOMBLE
Director
Jean-Luc MARTIN
Director
Jacques KUYPERS
Director
Director · represented by Jean-Claude DEDRY
Philippe NEVEN
Director
Jean-Loup BLONDEAU
Director
Didier SERTEYN
Director
Jean-Claude HAVAUX
Director
Alexandre DALLEMAGNE
Director
Joseph MARTIAL
Director
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Aye, Rue de la Science 8
6900 Marche-en-Famenne
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 14 companies are registered at this address.
All companies at this address →Association pour le développement des Productions Agroalimentaires de qualité
CER-Groupe
€ 22.4 million revenue · 2025
Association pour l'Usage et la Défense de l'Appellation Jambon d'Ardenne
Orgenesis (Belgium)
€ 1.4 million gross margin · 2021
ATB THERAPEUTICS same network
€ -513,236 gross margin · 2025
+9 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0541.682.642
- VAT number
- BE 0541.682.642
- Registered office
- Aye, Rue de la Science 8, 6900 Marche-en-Famenne
- Names & denominations
- RevaTis
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 6 November 2013
- Peppol
- Active · Active since 20 Nov 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Vervaardiging van geneesmiddelen
Speur- en ontwikkelingswerk op biotechnologisch gebied